- Trials with a EudraCT protocol (17)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
17 result(s) found for: Thermography.
Displaying page 1 of 1.
EudraCT Number: 2011-002212-81 | Sponsor Protocol Number: LIDOCAINCRPS | Start Date*: 2011-11-09 |
Sponsor Name:Klinik für Physikalische Medizin und Rehabilitation, Medizinische Universität Wien | ||
Full Title: Efficacy of Lidocaine medicated plaster in patients with CRPS: a pilot-study | ||
Medical condition: Complex Regional Pain Syndrome - CRPS lasting longer than 6 month | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003686-13 | Sponsor Protocol Number: P04805-V2.0 | Start Date*: 2007-05-31 | ||||||||||||||||
Sponsor Name:Allergie-Centrum-Charite, Department of Dermatology, Charite - Universitätsmedizin Berlin | ||||||||||||||||||
Full Title: An exploratory phase III, randomised, double blind, therapeutic single dose-related effect, parallel group study to assess and compare the effects of 5mg vs. 20mg Desloratadine on skin lesions in p... | ||||||||||||||||||
Medical condition: Chronic urticaria is characterized by the spontaneous development of wheal and flare type skin reactions. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-002444-24 | Sponsor Protocol Number: HS-18-638 | Start Date*: 2020-02-18 | |||||||||||
Sponsor Name:Camurus AB | |||||||||||||
Full Title: An Exploratory Trial Assessing Vascular Digital Perfusion, Pharmacokinetics, Safety and Tolerability Following a Single Dose of CAM2043 (Treprostinil Subcutaneous Depot) in Patients with Raynaud’s ... | |||||||||||||
Medical condition: Raynaud’s phenomenon secondary to systemic sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001602-33 | Sponsor Protocol Number: RR15/114 | Start Date*: 2015-09-22 | |||||||||||
Sponsor Name:The University of Leeds | |||||||||||||
Full Title: A single arm, phase II open label trial to investigate the efficacy and safety of intra-dermal injection of etanercept for remission induction in discoid lupus erythematosus | |||||||||||||
Medical condition: Discoid lupus erythematosus | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000640-21 | Sponsor Protocol Number: KetCRPS-2 | Start Date*: 2021-11-10 |
Sponsor Name:Center for Pain Medicine, Erasmus MC | ||
Full Title: Long-term pain modulation by intravenous esketamine in Complex Regional Pain Syndrome: a non-inferiority study | ||
Medical condition: Complex Regional Pain Syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-006133-32 | Sponsor Protocol Number: P04685 | Start Date*: 2006-09-20 | |||||||||||
Sponsor Name:Allergie-Centrum-Charité | |||||||||||||
Full Title: An exploratory phase IV, randomised, double-blind, placebo controlled crossover study to assess and compare the effects of 5 mg vs. 20 mg Desloratadine on the development of experimentally induced ... | |||||||||||||
Medical condition: Acquired cold urticaria (ACU) is a frequent form of physical urticaria that is characterized by the development of wheal and flare type skin reactions after cold exposure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003849-28 | Sponsor Protocol Number: CLS001-CO-PR-014-CHDR1639 | Start Date*: 2016-12-15 | |||||||||||
Sponsor Name:Cutanea Life Sciences | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study to assess the pharmacodynamics, safety, tolerability and efficacy of omiganan BID in patients with mild to moderate atopic dermatitis | |||||||||||||
Medical condition: Patients with mild to moderate atopic dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004316-31 | Sponsor Protocol Number: FPP4-DE-401 | Start Date*: 2009-02-23 | |||||||||||
Sponsor Name:Novartis Consumer Health S.A. | |||||||||||||
Full Title: A randomised, double-blind, vehicle controlled, single centre, parallel group, comparative study of the efficacy of penciclovir 10 mg/g (1%) cream in preventing the appearance of classical lesions ... | |||||||||||||
Medical condition: Cold Sores caused by the herpes simplex virus (HSV) type 1. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000866-22 | Sponsor Protocol Number: 01.01.08Jen | Start Date*: 2008-05-15 | |||||||||||
Sponsor Name:University of Aarhus, School of Dentistry | |||||||||||||
Full Title: Vurdering af det operative forløb i forbindelse med fjernelse af mandiblens 3. molar med særligt henblik på forekomsten af smerte og hævelse | |||||||||||||
Medical condition: pain after surgical removal of lower third molars | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000331-41 | Sponsor Protocol Number: CHDR1430 | Start Date*: 2016-03-22 | |||||||||||
Sponsor Name:Centre for Human Drug Research | |||||||||||||
Full Title: A randomized, open-label, vehicle-controlled, parallel, dose-ranging study to assess the pharmacodynamics of topically applied Imiquimod in healthy volunteers | |||||||||||||
Medical condition: none, this is a study on healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003471-39 | Sponsor Protocol Number: Miltefosin bei AD | Start Date*: 2007-08-24 |
Sponsor Name:Prof. Dr. med. Margitta Worm | ||
Full Title: Explorative analysis of topical miltefosine application in adult patients with atopic dermatitis. | ||
Medical condition: Atopic Dermatitis (AD) is a chronic, inflammatory skin disease combined with intense itching. Beside the existing genetic background, various environmental factors impact the pathophysiology. Topic... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004702-34 | Sponsor Protocol Number: CLS001-CO-PR-015 | Start Date*: 2017-01-09 | |||||||||||
Sponsor Name:Cutanea Life Sciences | |||||||||||||
Full Title: A randomized, evaluator-blinded, vehicle-controlled study to explore the pharmacodynamic effects of omiganan and omiganan in combination with imiquimod in healthy volunteers. | |||||||||||||
Medical condition: None | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003510-41 | Sponsor Protocol Number: CHDR1752-B | Start Date*: 2018-10-11 | |||||||||||
Sponsor Name:Centre for Human Drug Research | |||||||||||||
Full Title: Investigating anti-inflammatory effects of topical antibiotics in an LPS skin challenge model | |||||||||||||
Medical condition: Inflamed skin | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005627-32 | Sponsor Protocol Number: IIVOP | Start Date*: 2014-06-12 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge | |||||||||||||
Full Title: A randomised, double blind, placebo controlled crossover study of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model - an enriched population study | |||||||||||||
Medical condition: Neuropathic Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003203-35 | Sponsor Protocol Number: VP-C21-004 | Start Date*: 2019-12-13 | ||||||||||||||||
Sponsor Name:Vicore Pharma AB | ||||||||||||||||||
Full Title: A Phase 2, single-center, randomised, double-blind, placebo-controlled, cross-over, cold challenge study investigating the effect of C21 on cold-induced vasoconstriction in subjects with Raynaud’s ... | ||||||||||||||||||
Medical condition: Systemic sclerosis (SSc) Raynaud’s phenomenon (RP) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-002383-27 | Sponsor Protocol Number: CHDR1806 | Start Date*: 2019-08-01 | |||||||||||
Sponsor Name:Centre for Human Drug Research | |||||||||||||
Full Title: An exploratory, single-center, double-blinded, healthy volunteer controlled study to characterize psoriasis patients and explore novel biomarkers for the treatment response of psoriasis with a mult... | |||||||||||||
Medical condition: Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004179-35 | Sponsor Protocol Number: OSKNEEPA02 | Start Date*: 2012-04-30 | |||||||||||
Sponsor Name:C4Pain ApS | |||||||||||||
Full Title: A single center, randomized, double-blind, placebo-controlled 2-way crossover study to investigate the mechanism of action of etoricoxib in subjects with osteoarthritis knee pain | |||||||||||||
Medical condition: Osteoarthritic Knee Pain. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.